Potential Impact of Drug Dose and Body Weight on Treatment of ADHD Patients With a New Formulation of Methylphenidate Extended-Release Multilayer Beads (MPH-MLR)

New Research Poster Presentation 2.48
Potential Impact of Drug Dose and Body Weight on Treatment of ADHD Patients With a New Formulation of Methylphenidate Extended-Release Multilayer Beads (MPH-MLR)

Thursday, October 23, 2014 10:00 AM

Nathan Teuscher, PhD, PK/PD Associates, Trophy Club, TX

Akwete Lex Adjei, PhD, Rhodes Pharmaceuticals L.P., Coventry, RI

Robert Kupper, PhD, Rhodes Pharmaceuticals L.P., Coventry, RI

Ann Catherine Childress, MD,

Wei-Wei Chang, PhD, NuTec, Inc., Boston, MA

Sharon Wigal, AVIDA, Inc., Newport Beach, CA